laitimes

Wanfu Biotech, the leader in the rapid diagnosis of the new crown virus, 300482

author:Main information

The COVID-19 pandemic has swept the world, and remote prevention and control has become increasingly complex, bringing us new challenges. The economic losses caused by the quarantine of the epidemic and the physical and mental health of people.

Since the outbreak of the new crown epidemic, Wanfu Bio has been committed to providing new crown epidemic prevention and control products and related solutions, and is currently the only enterprise that has the new crown "antigen + antibody" China NMPA registration certificate at the same time, and has also obtained the EU CE related certification.

In view of the problems mentioned earlier, Dr. Kang Keren, Senior Vice President of Wanfu Biologics, will share the value of rapid covid-19 detection on remote prevention and control during the first World Shippers Conference, combined with the application experience of the new crown antigen detection technology and digital intelligence management system on the new crown epidemic, and answer questions and answer questions for the application of the new crown antigen detection on ships.